Deloitte has acquired Gryphon Scientific for an undisclosed sum as part of efforts to broaden its biosafety, biosecurity, public health and emergency preparedness and response capabilities.
Through the transaction, Deloitte said Monday it will absorb Gryphon’s scientists, programmers, data analysts, public health specialists and planning and policy professionals with experience in scientific communications, modeling, data science and risk assessment.
The two companies will also develop artificial intelligence applications through Deloitte’s Federal Health AI Accelerator to improve public health and safety and help customers prepare for chemical threats, biothreats and other biological emergencies.
Beth Meagher, U.S. federal health sector leader and principal at Deloitte Consulting, said the addition of Gryphon’s professionals and leadership reflects an enhancement to the consulting firm’s data analytics and advanced tech capabilities.
“Our federal health practice is excited to lead the way for U.S. government and public services (GPS) to push the boundaries and bring our clients to the forefront of AI-enabled, mission-driven work,” Meagher noted. “This enhances the types of data-driven technology and scientific experience that we can offer to federal agencies and strengthens our ability to support government leaders in their efforts to safeguard the security of our nation and the health and safety of our people.”
